Right.Brain Foundation e.V. Provides Advanced Navigation System to New...
MUNICH King Norodom Sihamoni and Prime Minister Hun Sen of Cambodia attended the inauguration of the first full-scale public Neurology Center that includes a 90-bed, $10.8 million dollar treatment...
View ArticleCSTが「最も優れた抗体」および「最も有益なウェブサイト」の部門でライフサイエンス・インダストリー・アワードを受賞
ワシントン (ビジネスワイヤ)– 抗体、キット、サービスを提供する一流企業のセル・シグナリング・テクノロジー(CST)は本日、「最も優れた抗体」(Best Antibodies)および「最も有益なウェブサイト」(Most Useful Website)の2部門でライフサイエンス・インダストリー・アワード(Life Science Industry...
View ArticleMerck Submits New Drug Application to the Japanese Pharmaceuticals and...
WHITEHOUSE STATION, N.J. Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the company has submitted a new drug application for omarigliptin, its...
View Article专业人士盛赞松下4K解决方案
日本大阪 (美国商业资讯)–松下公司于2014年11月19日发布视频,介绍了松下为推动影音行业发展而引领的4K解决方案的范例。 In addition to transforming TV broadcasts and images of all kinds, 4K is going to touch peoples’ lives with major solutions in a wide...
View ArticleResolutionMD® Receives Certification for Web and Mobile Diagnosis in Australia
CALGARY Calgary Scientific Inc., a company known for creating transformative technology for the medical industry and beyond, announced today that ResolutionMD® has received certification from the...
View ArticleAHF Global World AIDS Day Events Focus On Testing and Treatment
PHOTO: For World AIDS Day, AHF will host over 160 events around the world to promote testing, treatment for HIV/AIDS; international commemorations will launch global campaign to connect twenty...
View ArticleAHF在世界艾滋病日开展全球性活动,侧重于检测和治疗
(美国商业资讯) — 图片:在世界艾滋病日,AHF将在全球开展160多场活动,来推动HIV/艾滋病的检测和治疗;国际性的纪念活动将开展全球性运动,在2020年底前使2千万HIV阳性人士获得治疗。有关进一步信息,请访问www.aidshealth.org/wad (点击“世界各地的活动”标签查看国际性活动的列表。)...
View ArticleTakeda’s Investigational, Oral Proteasome Inhibitor Ixazomib Granted...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy status to the...
View Article武田研究中的用于复发或难治全身性轻链淀粉样变的口服蛋白酶体抑制剂Ixazomib被美国FDA认定为突破性治疗药物
马萨诸塞州坎布里奇和日本大阪 (美国商业资讯) –武田药品工业株式会社(TSE:4502)今天宣布,该公司研究中的用于治疗复发或难治全身性轻链(AL)淀粉样变的口服蛋白酶体抑制剂ixazomib (MLN9708) 被美国食品药品监督管理局(FDA)认定为突破性治疗药物。这是首个被认定为突破性治疗药物的蛋白酶体抑制剂和用于AL淀粉样变的研究药物。...
View Article再発性/難治性の全身性軽鎖アミロイドーシスの治療で、武田薬品の経口治験薬となるプロテアソーム阻害薬ixazomibが米FDAから画期的新薬の指定を受ける
米マサチューセッツ州ケンブリッジ & 大阪 — (ビジネスワイヤ) —...
View ArticleElekta Ltd and Medical Intelligence Medizintechnik GmbH defend claims by...
CRAWLEY, United Kingdom Regulatory News: humediQ GmbH has initiated legal proceedings against two companies in the Elekta (STO:EKTAB) (EKTA-B.ST) group. The dispute relates to an agreement from...
View ArticleBristol-Myers Squibb Foundation Awards Nine Grants Totaling More than $3.5...
NEW YORK The Bristol-Myers Squibb Foundation today announced nine new grants totaling more than $3.5 million to strengthen efforts in China and India in the fight against hepatitis B virus (HBV) and...
View Article8th Annual OneMedForum San Francisco Expands Its China Forum into Partnering...
NEW YORK OneMedForum announced today that its 8th annual OneMedForum conference, to be held at the San Francisco Marriott Marquis, Jan. 12-13, 2015, will expand its annual China Forum event at the...
View ArticleWipro Cited as a Major Contender in Everest Group 2014 PEAK Matrix™ for Payor...
BANGALORE, India & EAST BRUNSWICK, N.J. Wipro Ltd. (NYSE:WIT), a leading global information technology, consulting and business process services company, has been named a ‘Major Contender’ by...
View ArticleSt. Luke’s Medical Center-Global City Trusts UpToDate to Support Exceptional...
WALTHAM, Mass. Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that St. Luke’s Medical Center-Global City is among the...
View ArticleSeattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from...
SAN FRANCISCO Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today reported data demonstrating that Hodgkin lymphoma (HL) patients at risk of relapse...
View ArticleSeattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS®...
SAN FRANCISCO Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced four-year overall survival (OS) data from the ADCETRIS (brentuximab vedotin)...
View ArticleIntegra Holdings Closes $3 Million Investment from Guangxi Wuzhou...
JERUSALEM Integra Holdings, the biotechnology holdings company of Yissum, the technology transfer company of the Hebrew University of Jerusalem, announced today that it has received US $3 million...
View ArticleReal-Time, Responsive, Actionable Advice: ARDA Coaching Engine; a...
SAN FRANCISCO Performance Lab, developer of automated technology for fitness and health applications, today unveils the ARDATM Coaching Engine, a new, patented software platform that will redefine...
View Article